Literature DB >> 9560197

Protein-bound acrolein: potential markers for oxidative stress.

K Uchida1, M Kanematsu, K Sakai, T Matsuda, N Hattori, Y Mizuno, D Suzuki, T Miyata, N Noguchi, E Niki, T Osawa.   

Abstract

Acrolein (CH2==CH---CHO) is known as a ubiquitous pollutant in the environment. Here we show that this notorious aldehyde is not just a pollutant, but also a lipid peroxidation product that could be ubiquitously generated in biological systems. Upon incubation with BSA, acrolein was rapidly incorporated into the protein and generated the protein-linked carbonyl derivative, a putative marker of oxidatively modified proteins under oxidative stress. To verify the presence of protein-bound acrolein in vivo, the mAb (mAb5F6) against the acrolein-modified keyhole limpet hemocyanin was raised. It was found that the acrolein-lysine adduct, Nepsilon-(3-formyl-3, 4-dehydropiperidino)lysine, constitutes an epitope of the antibody. Immunohistochemical analysis of atherosclerotic lesions from a human aorta demonstrated that antigenic materials recognized by mAb5F6 indeed constituted the lesions, in which intense positivity was associated primarily with macrophage-derived foam cells and the thickening neointima of arterial walls. The observations that (i) oxidative modification of low-density lipoprotein with Cu2+ generated the acrolein-low-density lipoprotein adducts and (ii) the iron-catalyzed oxidation of arachidonate in the presence of protein resulted in the formation of antigenic materials suggested that polyunsaturated fatty acids are sources of acrolein that cause the production of protein-bound acrolein. These data suggest that the protein-bound acrolein represents potential markers of oxidative stress and long-term damage to protein in aging, atherosclerosis, and diabetes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9560197      PMCID: PMC20182          DOI: 10.1073/pnas.95.9.4882

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Plausible mechanism of inactivation of plasma alpha 1-proteinase inhibitor by acrolein.

Authors:  J C Gan; G A Ansari
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1987-03

3.  Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism.

Authors:  U P Steinbrecher; J L Witztum; S Parthasarathy; D Steinberg
Journal:  Arteriosclerosis       Date:  1987 Mar-Apr

4.  Low density lipoprotein undergoes oxidative modification in vivo.

Authors:  W Palinski; M E Rosenfeld; S Ylä-Herttuala; G C Gurtner; S S Socher; S W Butler; S Parthasarathy; T E Carew; D Steinberg; J L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

5.  Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.

Authors:  T Henriksen; E M Mahoney; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

6.  Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation.

Authors:  D W Morel; P E DiCorleto; G M Chisolm
Journal:  Arteriosclerosis       Date:  1984 Jul-Aug

7.  Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells.

Authors:  J W Heinecke; L Baker; H Rosen; A Chait
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

8.  Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein.

Authors:  J R Requena; M X Fu; M U Ahmed; A J Jenkins; T J Lyons; J W Baynes; S R Thorpe
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

9.  Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic.

Authors:  M K Cathcart; D W Morel; G M Chisolm
Journal:  J Leukoc Biol       Date:  1985-08       Impact factor: 4.962

10.  Differential modification of specificity in carbonic anhydrase catalysis.

Authors:  Y Pocker; N Janjić
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

View more
  143 in total

Review 1.  Good genes, oxidative stress and condition-dependent sexual signals.

Authors:  T von Schantz; S Bensch; M Grahn; D Hasselquist; H Wittzell
Journal:  Proc Biol Sci       Date:  1999-01-07       Impact factor: 5.349

2.  Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover.

Authors:  Xiongwei Zhu; Rudy J Castellani; Paula I Moreira; Gjumrakch Aliev; Justin C Shenk; Sandra L Siedlak; Peggy L R Harris; Hisashi Fujioka; Lawrence M Sayre; Pamela A Szweda; Luke I Szweda; Mark A Smith; George Perry
Journal:  Free Radic Biol Med       Date:  2011-11-12       Impact factor: 7.376

Review 3.  Urinary biomarkers of oxidative status.

Authors:  Dora Il'yasova; Peter Scarbrough; Ivan Spasojevic
Journal:  Clin Chim Acta       Date:  2012-06-07       Impact factor: 3.786

4.  Hydroxytyrosol protects retinal pigment epithelial cells from acrolein-induced oxidative stress and mitochondrial dysfunction.

Authors:  Zhongbo Liu; Lijuan Sun; Lu Zhu; Xu Jia; Xuesen Li; Haiqun Jia; Ying Wang; Peter Weber; Jiangang Long; Jiankang Liu
Journal:  J Neurochem       Date:  2007-12       Impact factor: 5.372

5.  Acrolein modification impairs key functional features of rat apolipoprotein E: identification of modified sites by mass spectrometry.

Authors:  Tuyen N Tran; Malathi G Kosaraju; Shiori Tamamizu-Kato; Olayemi Akintunde; Ying Zheng; John K Bielicki; Kent Pinkerton; Koji Uchida; Yuan Yu Lee; Vasanthy Narayanaswami
Journal:  Biochemistry       Date:  2014-01-08       Impact factor: 3.162

6.  Elevated neutrophil elastase and acrolein-protein adducts are associated with W256 regression.

Authors:  M Jaganjac; M Poljak-Blazi; R J Schaur; K Zarkovic; S Borovic; A Cipak; M Cindric; K Uchida; G Waeg; N Zarkovic
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

7.  Protein modification by acrolein: formation and stability of cysteine adducts.

Authors:  Jian Cai; Aruni Bhatnagar; William M Pierce
Journal:  Chem Res Toxicol       Date:  2009-04       Impact factor: 3.739

8.  Acrolein induces selective protein carbonylation in synaptosomes.

Authors:  C F Mello; R Sultana; M Piroddi; J Cai; W M Pierce; J B Klein; D A Butterfield
Journal:  Neuroscience       Date:  2007-06-14       Impact factor: 3.590

9.  Acrolein decreases endothelial cell migration and insulin sensitivity through induction of let-7a.

Authors:  Timothy E O'Toole; Wesley Abplanalp; Xiaohong Li; Nigel Cooper; Daniel J Conklin; Petra Haberzettl; Aruni Bhatnagar
Journal:  Toxicol Sci       Date:  2014-05-08       Impact factor: 4.849

10.  Glutathionylated 4-hydroxy-2-(E)-alkenal enantiomers in rat organs and their contributions toward the disposal of 4-hydroxy-2-(E)-nonenal in rat liver.

Authors:  Sushabhan Sadhukhan; Yong Han; Zhicheng Jin; Gregory P Tochtrop; Guo-Fang Zhang
Journal:  Free Radic Biol Med       Date:  2014-02-18       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.